BB Biotech

BB Biotech AG operates as a publicly traded investment company, offering specialized access to the biotechnology sector. The firm employs a rigorous, long-term investment strategy, leveraging deep biotech expertise to translate scientific breakthroughs into enduring value. This approach is characterized by disciplined capital deployment and high-conviction investment choices, executed by a multidisciplinary team combining scientific insight and financial acumen.

Established on November 9, 1993, in Schaffhausen, Switzerland, BB Biotech was founded on the insight that focused investment in the burgeoning biotechnology field presented significant opportunities. Its inception created a structured vehicle for capital to participate directly in the industry’s advancements and transformative potential.

The company serves investors seeking specialized exposure to the dynamic biotechnology landscape. BB Biotech's core vision is to identify and capitalize on biotech innovation, aiming to generate sustainable value through its investment platform. It remains dedicated to fostering novel medical solutions via strategic capital allocation.